Published in Ther Adv Psychopharmacol on October 01, 2012
Perceptions and knowledge of antipsychotics among mental health professionals and patients. BJPsych Bull (2017) 0.75
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry (2002) 5.25
Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res (2011) 4.22
A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry (2011) 3.71
Long-acting risperidone and oral antipsychotics in unstable schizophrenia. N Engl J Med (2011) 3.36
Systematic review of patient and nurse attitudes to depot antipsychotic medication. Br J Psychiatry (2001) 1.75
Patient choice in psychiatry. Br J Psychiatry (2007) 1.65
Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review. Br J Psychiatry Suppl (2009) 1.41
Psychiatrists' attitudes to maintenance medication for patients with schizophrenia. Psychol Med (2003) 1.22
Attitudes of psychiatrists toward antipsychotic depot medication. J Clin Psychiatry (2006) 1.21
Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review. Br J Psychiatry Suppl (2009) 1.19
Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia. Eur Psychiatry (2010) 1.09
Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years. J Psychopharmacol (2009) 1.06
Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists. Psychiatry Res (2009) 1.05
Depot and oral antipsychotics: patient preferences and attitudes are not the same thing. J Psychopharmacol (2008) 1.00
Prevalence and correlates of poor medication adherence amongst psychiatric outpatients in southwestern Nigeria. Gen Hosp Psychiatry (2009) 0.99
Are depot antipsychotics more coercive than tablets? The patient's perspective. J Psychopharmacol (2009) 0.99
Antipsychotic depot medication and attitudes of community psychiatric nurses. J Psychiatr Ment Health Nurs (2005) 0.94
Historical perspective on antipsychotic long-acting injections. Br J Psychiatry Suppl (2009) 0.92
Increased use of antipsychotic long-acting injections with community treatment orders. Ther Adv Psychopharmacol (2011) 0.89
Community treatment orders and antipsychotic long-acting injections. Br J Psychiatry Suppl (2009) 0.88
Medication adherence and quality of life among Nigerian outpatients with schizophrenia. Gen Hosp Psychiatry (2011) 0.87
Influx of fake drugs to Nigeria worries health experts. BMJ (2002) 0.85
The impact of family and budget structure on health treatment in Nigeria. Health Transit Rev (1991) 0.85
Prevalence and predictors of poor medication adherence among out-patients at a psychiatric hospital in Benin City, Nigeria. Int J Psychiatry Clin Pract (2010) 0.83
The place of observational studies in assessing the effectiveness of depot antipsychotics. Schizophr Res (2011) 0.82
Prognostic indicators for early discontinuation of risperidone long-acting injection. Int Clin Psychopharmacol (2004) 0.80
Psychiatric nurses' attitudes to antipsychotic depots in Hong Kong and comparison with London. J Psychiatr Ment Health Nurs (2008) 0.80
Mental health practitioner's attitude towards maintenance neuroleptic treatment for people with schizophrenia. J Psychiatr Ment Health Nurs (2007) 0.80
Health professionals' attitudes to depot injection antipsychotic medication: a systematic review. J Psychiatr Ment Health Nurs (2010) 0.80
A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry (2011) 3.71
The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services. J Clin Psychiatry (2015) 2.67
Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients. J Clin Psychiatry (2004) 1.16
Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr Bull (2014) 1.11
Antipsychotic long-acting injections: mind the gap. Br J Psychiatry Suppl (2009) 1.05
Prospective 6-month follow-up of patients prescribed risperidone long-acting injection: factors predicting favourable outcome. Int J Neuropsychopharmacol (2005) 0.92
A systematic review of aripiprazole--dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring. J Clin Psychiatry (2010) 0.91
Olanzapine: a systematic review and meta-regression of the relationships between dose, plasma concentration, receptor occupancy, and response. J Clin Psychopharmacol (2013) 0.89
Community treatment orders and antipsychotic long-acting injections. Br J Psychiatry Suppl (2009) 0.88
Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring. Ther Drug Monit (2014) 0.87
Risperidone and total 9-hydroxyrisperidone in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2002-2010. Ther Drug Monit (2012) 0.87
Burden of care among relatives of patients with schizophrenia in midwestern Nigeria. Int J Soc Psychiatry (2010) 0.84
The effect of long-acting risperidone on working memory in schizophrenia: a functional magnetic resonance imaging study. J Clin Psychopharmacol (2007) 0.84
Relationship between daily dose, plasma concentrations, dopamine receptor occupancy, and clinical response to quetiapine: a review. J Clin Psychiatry (2011) 0.83
The place of observational studies in assessing the effectiveness of depot antipsychotics. Schizophr Res (2011) 0.82
Unmodified electroconvulsive therapy: the perspective of patients from a developing country. J ECT (2010) 0.81
Prevalence of Toxoplasma gondii infection among individuals with severe mental illness in Nigeria: a case control study. Pathog Glob Health (2013) 0.81
Nigerian medical students attitudes to unmodified electroconvulsive therapy. J ECT (2009) 0.80
Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010. Hum Psychopharmacol (2012) 0.80
Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010. Early Interv Psychiatry (2012) 0.80
Attitudes to psychosis: health professionals. Epidemiol Psichiatr Soc (2005) 0.78
Clinician hesitation prior to clozapine initiation: is it justifiable? Br J Psychiatry (2012) 0.78
Plasma quetiapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2000-2011. Ther Adv Psychopharmacol (2013) 0.77
Depression and subjective quality of life among outpatients with diabetes mellitus at a teaching hospital in Nigeria. Ment Health Fam Med (2010) 0.76
Nigerian medical students' opinions about individuals who use and abuse psychoactive substances. Subst Abuse (2013) 0.75
Medication adherence and patient choice in mental health. Br J Hosp Med (Lond) (2011) 0.75